Position in ABBV
as of Jun 30, 2026
· filed Jul 23, 2026
Position Value
$2,265,766
+$303,572 QoQ
Shares Held
9,004
-0.2% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
1.10%
of 13F equity value
Holder Rank
#1,871
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026JNBA Financial Advisors holds $8,063,885 across 15 Drug Manufacturers - General names. ABBV ranks #1 (28.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
This page
|
9,004 | $2,265,766 | |
| 2 | JNJ |
Johnson & Johnson
|
7,699 | $1,955,315 | |
| 3 | NVS |
Novartis AG
|
6,281 | $984,358 | |
| 4 | MRK |
Merck & Co., Inc.
|
5,494 | $705,979 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
4,283 | $541,114 | |
| 6 | LLY |
ELI LILLY & Co
|
450 | $539,743 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
5,281 | $304,291 | |
| 8 | AMGN |
Amgen Inc
|
657 | $237,912 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,265,766 | 9,004 | Shares | Sole | 2026-07-23 | |
| 2026-03-31 | $1,962,194 | 9,022 | Shares | Sole | 2026-04-23 | |
| 2025-12-31 | $2,102,336 | 9,201 | Shares | Sole | 2026-01-26 | |
| 2025-09-30 | $2,170,224 | 9,373 | Shares | Sole | 2025-10-28 | |
| 2025-06-30 | $1,725,523 | 9,296 | Shares | Sole | 2025-07-24 | |
| 2025-03-31 | $1,947,697 | 9,296 | Shares | Sole | 2025-04-25 | |
| 2024-12-31 | $1,611,916 | 9,071 | Shares | Sole | 2025-01-30 | |
| 2024-09-30 | $1,796,475 | 9,097 | Shares | Sole | 2024-10-31 | |
| 2024-06-30 | $1,560,317 | 9,097 | Shares | Sole | 2024-07-22 | |
| 2024-03-31 | $1,634,711 | 8,977 | Shares | Sole | 2024-04-26 | |
| 2023-12-31 | $1,426,963 | 9,208 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $1,362,706 | 9,142 | Shares | Sole | 2023-11-02 | |
| 2023-06-30 | $1,263,363 | 9,377 | Shares | Sole | 2023-08-03 | |
| 2023-03-31 | $1,489,631 | 9,347 | Shares | Sole | 2023-05-02 | |
| 2022-12-31 | $1,571,334 | 9,723 | Shares | Sole | 2023-02-07 | |
| 2022-09-30 | $1,347,736 | 10,042 | Shares | Sole | 2022-11-07 | |
| 2022-06-30 | $1,562,844 | 10,204 | Shares | Sole | 2022-07-22 | |
| 2022-03-31 | $1,642,660 | 10,133 | Shares | Sole | 2022-04-29 | |
| 2021-12-31 | $1,448,238 | 10,696 | Shares | Sole | 2022-02-03 | |
| 2021-09-30 | $1,171,576 | 10,861 | Shares | Sole | 2021-11-10 | |
| 2021-06-30 | $1,223,383 | 10,861 | Shares | Sole | 2021-08-04 | |
| 2021-03-31 | $1,175,377 | 10,861 | Shares | Sole | 2021-05-03 | |
| 2020-12-31 | $1,136,325 | 10,605 | Shares | Sole | 2021-01-25 | |
| 2020-09-30 | $925,037 | 10,561 | Shares | Sole | 2020-11-05 | |
| 2020-06-30 | $1,041,787 | 10,611 | Shares | Sole | 2020-07-24 | |
| 2020-03-31 | $805,633 | 10,574 | Shares | Sole | 2020-05-01 | |
| No filing history on record for this holder in this stock. | ||||||